World Class Benchmarking
Asics Corp – World Class Benchmarking
Asics Corporation (7936 JP): Profitable Growth rank of 2 was up compared to the prior period’s 4th rank. This is World Class performance compared to 950 large Cons. Disc. companies worldwide.
Read MorePuma SE – World Class Benchmarking
Puma SE (PUM GR): Profitable Growth rank of 6 was down compared to the prior period’s 4th rank. This is below average performance compared to 950 large Cons. Disc. companies worldwide.
Read MoreTyson Foods – World Class Benchmarking
Tyson Foods Incorporated (TSN US): Profitable Growth rank of 9 was down compared to the prior period’s 3rd rank. This is poor performance compared to 560 large Cons. Staples companies worldwide.
Read MoreNike – World Class Benchmarking
Nike Incorporated (NKE US): Profitable Growth rank of 1 was up compared to the prior period’s 2nd rank. This is World Class performance compared to 950 large Cons. Disc. companies worldwide.
Read MoreAdidas – World Class Benchmarking
Adidas AG (ADS GR): Profitable Growth rank of 10 was down compared to the prior period’s 8th rank. This is poor performance compared to 950 large Cons. Disc. companies worldwide.
Read MoreJohnson & Johnson – World Class Benchmarking
Johnson & Johnson (JNJ US): Profitable Growth rank of 1 was up compared to the prior period’s 2nd rank. This is World Class performance compared to 380 large Health Care companies worldwide.
Read MoreSinovac Biotech – World Class Benchmarking
Sinovac Biotech Limited (SVA US): Profitable Growth rank of 8 was same compared to the prior period’s 8th rank. This is below average performance compared to 400 medium Health Care companies worldwide.
Read MorePfizer – World Class Benchmarking
Pfizer Incorporated (PFE US): Profitable Growth rank of 5 was down compared to the prior period’s 1st rank. This is average performance compared to 380 large Health Care companies worldwide.
Read MoreAstraZeneca – World Class Benchmarking
AstraZeneca PLC (AZN LN): Profitable Growth rank of 4 was down compared to the prior period’s 3rd rank. This is above average performance compared to 380 large Health Care companies worldwide.
Read MoreSinopharm Group – World Class Benchmarking
Sinopharm Group Company Limited (1099 HK): Profitable Growth rank of 8 was same compared to the prior period’s 8th rank. This is below average performance compared to 380 large Health Care companies worldwide.
Read More